Eli Lilly continues to dominate the obesity market with Zepbound and Orforglipron, leading JPMorgan to see it as a top pick ...

Since the FDA said shortages of Wegovy and Zepbound are over, compounding pharmacies are supposed to stop making copies of the drugs. But some of those business are trying to find ways to continue.

Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...

The obesity treatment market is booming, with groundbreaking drugs like Eli Lilly's (NYSE: LLY) Zepbound delivering ...

Donation Options Search Search Search Boxes of the weight-loss medications Wegovy and Zepbound. JoNel Aleccia / AP Share Excess body weight can raise the risk of certain cancers. So researchers ...

These figures, as noted by Binance, could be subject to revision based on prevailing market conditions. HYPE is also expected to be included in Binance’s Futures Copy Trading programme within 24 ...

Over the past few years, demand for blockbuster medications like Ozempic, Wegovy and Zepbound skyrocketed ... As a result, a market for cheaper, off-brand versions of their active ingredients ...

With many traders out and liquidity already light, the market was primed for a rumor to spark an outsized reaction. This wasn’t just a bad headline — it was the wrong headline, at the wrong ...

A U.S. federal court ruling blocking President Trump's 'Liberation Day' tariffs stirred mixed market reactions. Stocks fluctuated while the dollar initially rallied, then weakened. Analysts are ...

Adding to market uncertainty, a US Appeals Court has reinstated former President Donald Trump’s “reciprocal tariffs” just one day after they were struck down by the US Court of International Trade, ...

INDIANAPOLIS, May 29, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro ...

Amid renewed tariff threats and suddenly kinetic bond yields, special attention will be paid to any data set that could trigger a market reaction. Both services and manufacturing purchasing ...